BioSpace News Archive

Policy

WHO Delays Authorization of Russia’s Sputnik V Indefinitely

On Wednesday, the World Health Organization indefinitely postponed the evaluation of Russia’s Sputnik V COVID-19 vaccine due to the ongoing conflict in Ukraine.

March 17, 2022
·
2 min read
·
Alex Keown
FDA

COVID-19 Update: The Diabetes Connection, WHO Concerned about BA.2

There is some evidence that COVID-19 infection might be linked to an increase in diabetes, particularly Type 1 diabetes, which is an autoimmune disease most commonly diagnosed in children.

March 17, 2022
·
8 min read
·
Mark Terry
FDA

Tetra’s Opioid Pain Alternative Moving Closer to FDA Approval

Tetra Bio-Pharma announced that its investigational new drug involving cannabinoids, QIXLEEF, received guidance to strengthen its nonclinical and toxicological data from the FDA.

March 17, 2022
·
3 min read
·
Hayley Shasteen
Business

BioSpace Movers & Shakers: Enveda, Evaxion, Elevation

Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.

March 17, 2022
·
7 min read
·
Alex Keown
Drug Development

Intranasal COVID Vaccine Offers Hope Against Subvariants

Codagenix is entering the vaccine arena with a possible new frontrunner in protection: CoviLiv. It’s an intranasal COVID vaccine that provides hope against subvariants.

March 17, 2022
·
3 min read
·
Hayley Shasteen
Career Advice

How to Know if Remote Work is Right for You

Just because everyone around you seems to be switching to a work-from-home position does not mean it is the right decision for you. It’s important to weigh the options carefully before you decide.

March 17, 2022
·
5 min read
·
Kaley Lefevre
Drug Development

Appeals Court Upholds Decision for Mylan Generic of Biogen MS Drug

The U.S. Court of Appeals for the Federal Circuit denied Biogen a second look into the patent dispute filed against Mylan for Biogen’s Multiple Sclerosis (MS) drug, Tecfidera.

March 17, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

AbbVie’s Rinvoq Breaks into Gastroenterology Space with UC Approval

This is the first approval for the drug in gastroenterology and was based on data from three Phase III trials.

March 17, 2022
·
2 min read
·
Mark Terry
The Missing Piece: CPOs are Bringing Patients’ Voices to the Table

Biopharma is heeding the call and many pharmaceutical companies are working towards including patient communities in their work.

March 17, 2022
·
6 min read
·
Hayley Shasteen
Business

AstraZeneca May Abandon US Regulatory Efforts for COVID-19 Vaccine

Sir Mene Pangalos said the company was considering not submitting it to the FDA if it finds it is “banging its head against a brick wall indefinitely.”

March 17, 2022
·
2 min read
·
Mark Terry